Cover Image

Impact of metabolic syndrome on development of castration-resistant prostate cancer

Saved in:

Bibliographic Details
Date:	2017
Main Authors:	Ju. A. Vinnik, T. A. Nalbandjan
Format:	Article
Language:	English
Published:	2017
Series:	International medical journal
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000682582
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

The effect of metabolic syndrome on prostatic cancer development
by: T. A. Nalbandjan
Published: (2016)

Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
by: A. N. Dubinina
Published: (2016)

Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020)

Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia
by: V. V. Bentrad, et al.
Published: (2020)

Effects of cytokine-like polypeptide emap ii and flutamide on testosterone-stimulated prostate of castrated rats
by: O. H. Reznikov, et al.
Published: (2011)

Morpholoogical features of castratoin-resistent prostate cancer
by: L. H. Rosha, et al.
Published: (2018)

The impact of hydroxycitric acid on the lipid metabolism profile under experimental insulin resistance syndrome of Syrian hamsters
by: A. L. Zagayko, et al.
Published: (2016)

Development of gene expression panels to determine prostate cancer
by: G. V. Gerashchenko, et al.
Published: (2019)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)

NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)

Precision therapy to target apoptosis in prostate cancer
by: G. Kulik
Published: (2014)

The development of dysbiosis and hepatitis into rats with experimental metabolic syndrome
by: A. P. Levitskij, et al.
Published: (2016)

Implication of protocadherin-PC in the progression of the advanced prostate cancer
by: Giannakopoulos, X., et al.
Published: (2007)

Survival rates of familial and sporadic prostate cancer patients
by: J. Plonis, et al.
Published: (2015)

Paraneoplastic syndrome in hepatocellular cancer
by: Ju. V. Dumanskij, et al.
Published: (2013)

Indicators of lipid metabolism disorders in the blood serum of adolescents with metabolic syndrome
by: L. A. Strashok, et al.
Published: (2020)

Expression of proteins of polyamine metabolism ferments in human prostate malignant tumors
by: S. V. Hohol
Published: (2019)

Modern algorithm of treatment of patients with prostate cancer with bone metastases
by: O. V. Ponomareva, et al.
Published: (2017)

Non-standard case of cancer of prostate gland (clinical case)
by: O. M. Zacheslavskyi, et al.
Published: (2018)

Expression pattern of genes associated with tumor microenvironment in prostate cancer
by: Gerashchenko, G.V., et al.
Published: (2018)

Modern ideas about the development of metabolic syndrome and its correction by bioflavonoids
by: O. A. Makarenko, et al.
Published: (2015)

Modern view on the problem of metabolic syndrome (review)
by: Yu. M. Hryshko
Published: (2018)

Therapeutic correction of atherogenic dyslipidemia at metabolic syndrome
by: T. N. Ambrosova
Published: (2013)

Endocrine status of patients with osteoarthritis and metabolic syndrome
by: L. N. Yefremenkova
Published: (2015)

Blood and urine polyamine as new diagnostic markers of prostate cancer
by: S. P. Zalietok, et al.
Published: (2019)

Amplification and co-regulators of androgen receptor gene in prostate cancer
by: Golias, Ch., et al.
Published: (2009)

Assessment of gold nanoparticle effect on prostate cancer LNCaP cells
by: A. G. Reznikov, et al.
Published: (2015)

Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: O. A. Chernichenko, et al.
Published: (2014)

Evaluation of genetic markers of bone metabolism in patients with maxillofacial anomalieson the baskground of metabolic syndrome
by: A. E. Denga, et al.
Published: (2020)

Biochemical and cytogenetic indices of peripheral blood lymphocytes in patients with prostate cancer
by: E. A. Domina, et al.
Published: (2018)

Role of adipose tissue and adipokines in chronic inflammation development on metabolic syndrome background
by: N. A. Shutova, et al.
Published: (2021)

Morphological abnormalities in testes and epididymises of rats with metabolic syndrome developed in the juvenile age
by: Ye. Tkachenko, et al.
Published: (2017)

Immunological aspects of lipid metabolism in patients with nephrotic syndrome
by: N. V. Zhabotinskaja
Published: (2013)

Insulin determination in pancreas of guinea pigs with metabolic syndrome
by: V. V. Rushchak, et al.
Published: (2014)

Features of cardioremodeling in patients with arterial hypertension and metabolic syndrome
by: V. M. Bondar, et al.
Published: (2016)

Search for genes – potential markers of aggressiveness and metastasis for human prostate cancer
by: E. E. Rozenberh, et al.
Published: (2013)

Apoptosis of peripheral blood lymphocytes of prostate cancer patients induced by in vitro irradiation
by: A. A. Filchenkov, et al.
Published: (2019)

Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)

Dynamics of prostate cancer rate and mortality in Ukraine: current state of aff airs
by: Yu. Kobilnyk, et al.
Published: (2020)

Health-dependent quality of life in patients with disseminated hormone-naive prostate cancer
by: V. N. Lesovoj, et al.
Published: (2016)